939805-29-5 Usage
Description
Thiazole, 4-[3-(trifluoromethyl)phenyl]is a chemical compound that belongs to the thiazole family. Its molecular structure consists of a thiazole ring with a trifluoromethylphenyl group attached to the fourth position. The trifluoromethyl group provides unique properties to the compound, making it valuable in various scientific applications.
Uses
Used in Pharmaceutical Industry:
Thiazole, 4-[3-(trifluoromethyl)phenyl]is used as a potential building block for the synthesis of bioactive molecules in the field of medicinal chemistry. Its unique properties make it valuable for the development of drugs.
Used in Agrochemicals:
Thiazole, 4-[3-(trifluoromethyl)phenyl]can be utilized in agrochemicals, where its properties can contribute to the development of effective and innovative products.
Used in Materials Science Research:
Thiazole, 4-[3-(trifluoromethyl)phenyl]can also be employed in materials science research, where its unique properties can be explored for various applications.
It is important to handle Thiazole, 4-[3-(trifluoromethyl)phenyl]with care and follow proper safety protocols due to its potential hazards.
Check Digit Verification of cas no
The CAS Registry Mumber 939805-29-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,9,8,0 and 5 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 939805-29:
(8*9)+(7*3)+(6*9)+(5*8)+(4*0)+(3*5)+(2*2)+(1*9)=215
215 % 10 = 5
So 939805-29-5 is a valid CAS Registry Number.
939805-29-5Relevant articles and documents
Novel series of 3-amino-N-(4-aryl-1,1-dioxothian-4-yl)butanamides as potent and selective dipeptidyl peptidase IV inhibitors
Nitta, Aiko,Fujii, Hideaki,Sakami, Satoshi,Satoh, Mikiya,Nakaki, Junko,Satoh, Shiho,Kumagai, Hiroki,Kawai, Hideki
, p. 7036 - 7040 (2013/01/15)
A series of novel 3-amino-N-(4-aryl-1,1-dioxothian-4-yl)butanamides were investigated as dipeptidyl peptidase IV (DPP-4) inhibitors. Introduction of a 4-phenylthiazol-2-yl group showed highly potent DPP-4 inhibitory activity. Among various derivatives, (3R)-3-amino-N-(4-(4-phenylthiazol-2-yl)-tetrahydro-2H- thiopyran-4-yl)-4-(2,4,5-trifluorophenyl)butanamide 1,1-dioxide (30) reduced blood glucose excursion in an oral glucose tolerance test by oral administration.
